Reversible molecular pathology of skeletal muscle in spinal muscular atrophy

Human Molecular Genetics

Volumn 20, Issue 22, 2011, Pages 4334-4344

  Mutsaers, Chantal A ^a   Wishart, Thomas M ^a   Lamont, Douglas J ^b   Riessland, Markus ^c   Schreml, Julia ^c   Comley, Laura H ^a   Murray, Lyndsay M ^a   Parson, Simon H ^a   Lochmüller, Hanns ^d   Wirth, Brunhilde ^c   Talbot, Kevin ^e   Gillingwater, Thomas H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF COLOGNE   (Germany)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE H2AX; PARVALBUMIN; PHOSPHOPROTEIN; VOLTAGE DEPENDENT ANION CHANNEL 2; VORINOSTAT;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DNA DAMAGE; DOWN REGULATION; HUMAN; HUMAN TISSUE; LEVATOR AURIS LONGUS MUSCLE; MOLECULAR PATHOLOGY; MOTONEURON; MOUSE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DENERVATION; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEOMICS; SCHOOL CHILD; SKELETAL MUSCLE; SPINAL MUSCULAR ATROPHY; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY, SPINAL; SMN COMPLEX PROTEINS; SURVIVAL OF MOTOR NEURON 1 PROTEIN; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

MUS;

EID: 80054880080     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr360     Document Type: Article

References (62)

1. Pearn, J. (1978) Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med. Genet., 15, 409-413.
2. Wirth, B. (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat., 15, 228-237.
3. Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80, 155-165.
4. Burghes, A.H. and Beattie, C.E. (2009) Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?, Nat. Rev. Neurosci., 10, 597-609.
5. Lorson, C.L., Rindt, H. and Shababi, M. (2010) Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum. Mol. Genet., 19, R111-R118.
6. Swoboda, K.J., Prior, T.W., Scott, C.B., McNaught, T.P., Wride, M.C., Reyna, S.P. and Bromberg, M.B. (2005) Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann. Neurol., 57, 704-712.
7. Lunn, M.R. and Wang, C.H. (2008) Spinal muscular atrophy. Lancet, 371, 2120-2133.
8. Murray, L.M., Talbot, K. and Gillingwater, T.H. (2010) Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol., 36, 133-156.
9. Sleigh, J.N., Gillingwater, T.H. and Talbot, K. (2011) The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy. Dis. Model. Mech., 4, 457-467.
10. Fidziańska, A., Goebel, H.H. and Warlo, I. (1990) Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain, 113, 433-445.
11. Tews, D.S. and Goebel, H.H. (1997) Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J. Neuropathol. Exp. Neurol., 56, 150-156.
12. Guettier-Sigrist, S., Hugel, B., Coupin, G., Freyssinet, J.M., Poindron, P. and Warter, J.M. (2002) Possible pathogenic role of muscle cell dysfunction in motor neuron death in spinal muscular atrophy. Muscle Nerve, 25, 700-708.
13. Stathas, D., Kalfakis, N., Kararizou, E. and Manta, P. (2008) Spinal muscular atrophy: DNA fragmentation and immaturity of muscle fibers. Acta Histochem., 110, 53-58.
14. Dachs, E., Hereu, M., Piedrafita, L., Casanovas, A., Calderó, J. and Esquerda, J.E. (2011) Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J. Neuropathol. Exp. Neurol., 70, 444-461.
15. Chan, Y.B., Miguel-Aliaga, I., Franks, C., Thomas, N., Trülzsch, B., Sattelle, D.B., Davies, K.E. and van den Heuvel, M. (2003) Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum. Mol. Genet., 12, 1367-1376.
16. Gavrilina, T.O., McGovern, V.L., Workman, E., Crawford, T.O., Gogliotti, R.G., DiDonato, C.J., Monani, U.R., Morris, G.E. and Burghes, A.H. (2008) Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum. Mol. Genet., 17, 1063-1075.
17. Braun, S., Croizat, B., Lagrange, M.C., Warter, J.M. and Poindron, P. (1995) Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet, 345, 694-695.
18. Greensmith, L. and Vrbová, G. (1997) Disturbances of neuromuscular interaction may contribute to muscle weakness in spinal muscular atrophy. Neuromuscul. Disord., 7, 369-372.
19. Cifuentes-Diaz, C., Frugier, T., Tiziano, F.D., Lacène, E., Roblot, N., Joshi, V., Moreau, M.H. and Melki, J. (2001) Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J. Cell Biol., 152, 1107-1114.
20. Arnold, A.S., Gueye, M., Guettier-Sigrist, S., Courdier-Fruh, I., Coupin, G., Poindron, P. and Gies, J.P. (2004) Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients. Lab. Invest., 84, 1271-1278.
21. Shafey, D., Côté, P.D. and Kothary, R. (2005) Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp. Cell Res., 311, 49-61.
22. Rajendra, T.K., Gonsalvez, G.B., Walker, M.P., Shpargel, K.B., Salz, H.K. and Matera, A.G. (2007) A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle. J. Cell Biol., 176, 831-841.
23. Vrbova, G. (2008) Spinal muscular atrophy: motoneurone or muscle disease? Neuromuscul. Disord., 18, 81-82.
24. Martínez-Hernández, R., Soler-Botija, C., Also, E., Alias, L., Caselles, L., Gich, I., Bernal, S. and Tizzano, E.F. (2009) The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J. Neuropathol. Exp. Neurol., 68, 474-481.
25. Walker, M.P., Rajendra, T.K., Saieva, L., Fuentes, J.L., Pellizzoni, L. and Matera, A.G. (2008) SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum. Mol. Genet., 17, 3399-3410.
26. Anderson, K., Potter, A., Baban, D. and Davies, K.E. (2003) Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain, 126, 2052-2064.
27. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossoll, W., Prior, T.W. et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(2/2) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 9, 333-339.
28. Murray, L.M., Gillingwater, T.H. and Parson, S.H. (2010) Using mouse cranial muscles to investigate neuromuscular pathology in vivo. Neuromuscul. Disord., 20, 740-743.
29. Murray, L.M., Comley, L.H., Thomson, D., Parkinson, N., Talbot, K. and Gillingwater, T.H. (2008) Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 949-962.
30. Murray, L.M., Sheena, L., Bäumer, D., Parson, S.H., Talbot, K. and Gillingwater, T.H. (2010) Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum. Mol. Genet., 19, 420-433.
31. Bäumer, D., Lee, S., Nicholson, G., Davies, J.L., Parkinson, N.J., Murray, L.M., Gillingwater, T.H., Ansorge, O., Davies, K.E. and Talbot, K. (2009) Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet., 5, e1000773.
32. Ruiz, R., Casañas, J.J., Torres-Benito, L., Cano, R. and Tabares, L. (2010) Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J. Neurosci., 30, 849-857.
33. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A.J., Yang, W.S., Fridman, D.J., Wolpaw, A.J., Smukste, I., Peltier, J.M., Boniface, J.J. et al. (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature, 447, 864-868.
34. Yamagata, H., Shimizu, S., Nishida, Y., Watanabe, Y., Craigen, W.J. and Tsujimoto, Y. (2009) Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax. Oncogene, 28, 3563-3572.
35. Plesca, D., Mazumder, S. and Almasan, A. (2008) DNA damage response and apoptosis. Methods Enzymol., 446, 107-122.
36. Wen, W., Zhu, F., Zhang, J., Keum, Y.S., Zykova, T., Yao, K., Peng, C., Zheng, D., Cho, Y.Y., Ma, W.Y. et al. (2010) MST1 promotes apoptosis through phosphorylation of histone H2AX. J. Biol. Chem., 285, 39108-39116.
37. Li, Z., Lehar, M., Samlan, R. and Flint, P. (2005) Proteomic analysis of rat laryngeal muscle following denervation. Proteomics, 5, 4764-4776.
38. Sun, H., Liu, J., Ding, F., Wang, X., Liu, M. and Gu, X. (2006) Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation. J. Muscle Res. Cell Motil., 27, 241-250.
39. Sato, Y., Shimizu, M., Mizunoya, W., Wariishi, H., Tatsumi, R., Buchman, V. and Ikeuchi, Y. (2009) Differential expression of sarcoplasmic and myofibrillar proteins of rat soleus muscle during denervation atrophy. Biosci. Biotechnol. Biochem., 73, 1748-1756.
40. Wirth, B., Brichta, L. and Hahnen, E. (2006) Spinal muscular atrophy and therapeutic prospects. Prog. Mol. Subcell. Biol., 44, 109-132.
41. Riessland, M., Ackermann, B., Förster, A., Jakubik, M., Hauke, J., Garbes, L., Fritzsche, I., Mende, Y., Blumcke, I., Hahnen, E. et al. (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum. Mol. Genet., 19, 1492-1506.
42. Henderson, C.E., Hauser, S.L., Huchet, M., Dessi, F., Hentati, F., Taguchi, T., Changeux, J.P. and Fardeau, M. (1987) Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons. Neurology, 37, 1361-1364.
43. Sen, A., Yokokura, T., Kankel, M.W., Dimlich, D.N., Manent, J., Sanyal, S. and Artavanis-Tsakonas, S. (2011) Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling. J. Cell Biol., 192, 481-495.
44. Bosch-Marcé, M., Wee, C.D., Martinez, T.L., Lipkes, C.E., Choe, D.W., Kong, L., Van Meerbeke, J.P., Musaro', A. and Sumner, C.J. (2011) Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum. Mol. Genet., 20, 1844-1853.
45. Abe, S., Hirose, D., Kado, S., Iwanuma, O., Saka, H., Yanagisawa, N. and Ide, Y. (2009) Increased expression of decorin during the regeneration stage of mdx mouse. Anat. Sci. Int., 84, 305-311.
46. Zhang, Y., Ye, J., Chen, D., Zhao, X., Xiao, X., Tai, S., Yang, W. and Zhu, D. (2006) Differential expression profiling between the relative normal and dystrophic muscle tissues from the same LGMD patient. J. Transl. Med., 4, 53.
47. Svensson, A. and Tågerud, S. (2009) Galectin-1 expression in innervated and denervated skeletal muscle. Cell. Mol. Biol. Lett., 14, 128-138.
48. Grossi, A., Lametsch, R., Karlsson, A.H. and Lawson, M.A. (2011) Mechanical stimuli on C2C12 myoblasts affect myoblast differentiation, focal adhesion kinase phosphorylation and galectin-1 expression: a proteomic approach. Cell Biol. Int., 35, 579-586.
49. Higuchi, I., Hashiguchi, A., Matsuura, E., Higashi, K., Shiraishi, T., Hirata, N., Arimura, K. and Osame, M. (2007) Different pattern of HSP47 expression in skeletal muscle of patients with neuromuscular diseases. Neuromuscul. Disord., 17, 221-226.
50. de Morrée, A., Hensbergen, P.J., van Haagen, H.H., Dragan, I., Deelder, A.M., 't Hoen, P.A., Frants, R.R. and van der Maarel, S.M. (2010) Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity. PLoS One, 5, e13854.
51. Cheng, E.H., Sheiko, T.V., Fisher, J.K., Craigen, W.J. and Korsmeyer, S.J. (2003) VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science, 301, 513-517.
52. Roy, S.S., Ehrlich, A.M., Craigen, W.J. and Hajnóńczky, G. (2009) VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria. EMBO Rep., 10, 1341-1347.
53. 2+ signaling in cardiac myocytes. Cell Calcium, 49, 136-143.
54. O'Connell, K. and Ohlendieck, K. (2009) Proteomic DIGE analysis of the mitochondria-enriched fraction from aged rat skeletal muscle. Proteomics, 9, 5509-5524.
55. Massa, R., Marliera, L.N., Martorana, A., Cicconi, S., Pierucci, D., Giacomini, P., De Pinto, V. and Castellani, L. (2000) Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle. J. Muscle Res. Cell Motil., 21, 433-442.
56. Gailly, P. (2002) New aspects of calcium signaling in skeletal muscle cells: implications in Duchenne muscular dystrophy. Biochim. Biophys. Acta, 1600, 38-44.
57. Rome, L.C. (2006) Design and function of superfast muscles: new insights into the physiology of skeletal muscle. Annu. Rev. Physiol., 68, 193-221.
58. Hockly, E., Richon, V.M., Woodman, B., Smith, D.L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P.A. et al. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA, 100, 2041-2046.
59. Hahnen, E., Eyüpoglu, I.Y., Brichta, L., Haastert, K., Tränkle, C., Siebzehnrübl, F.A., Riessland, M., Hölker, I., Claus, P., Romstöck, J. et al. (2006) In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J. Neurochem., 98, 193-202.
60. Wishart, T.M., Huang, J.P., Murray, L.M., Lamont, D.J., Mutsaers, C.A., Ross, J., Geldsetzer, P., Ansorge, O., Talbot, K., Parson, S.H. et al. (2010) SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy. Hum. Mol. Genet., 19, 4216-4228.
61. Comley, L.H., Fuller, H.R., Wishart, T.M., Mutsaers, C.A., Thomson, D., Wright, A.K., Ribchester, R.R., Morris, G.E., Parson, S.H., Horsburgh, K. et al. (2011) ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum. Mol. Genet., 20, 2406-2421.
62. Wishart, T.M., Paterson, J.M., Short, D.M., Meredith, S., Robertson, K.A., Sutherland, C., Cousin, M.A., Dutia, M.B. and Gillingwater, T.H. (2007) Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol. Cell. Proteomics, 6, 1318-1330.